Public issue of 70,50,000 equity shares of Rs. 10 each at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) for cash aggregating upto Rs. [*] crores (Issue) including employee reservation portion of upto 50,000 equity shares, by Calyx Chemicals and Pharmaceuticals Limited (Company or Issuer). The issue less the employee reservation portion is referred to as the net issue. The issue will constitute 30.05% of the fully diluted post issue paid-up capital of the company. The net issue to public will constitute 29.83% of the fully diluted post issue paid-up capital of the company.